These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37503635)

  • 1. Bacterial sexually transmitted infections are concentrated in subpopulations of men who have sex with men using HIV pre-exposure prophylaxis.
    Jongen VW; Van Der Loeff MFS; Van Den Elshout M; Wijstma E; Coyer L; Davidovich U; De Vries HJC; Prins M; Hoornenborg E; Boyd A
    AIDS; 2023 Nov; 37(13):2059-2068. PubMed ID: 37503635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort.
    van den Elshout MAM; Wijstma ES; Boyd A; Jongen VW; Coyer L; Anderson PL; Davidovich U; de Vries HJC; Prins M; Schim van der Loeff MF; Hoornenborg E;
    PLoS Med; 2024 May; 21(5):e1004328. PubMed ID: 38718068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can we screen less frequently for STI among PrEP users? Assessing the effect of biannual STI screening on timing of diagnosis and transmission risk in the AMPrEP Study.
    Jongen VW; Zimmermann HML; Goedhart M; Bogaards JA; Davidovich U; Coyer L; de Vries HJC; Prins M; Hoornenborg E; Schim van der Loeff MF;
    Sex Transm Infect; 2023 May; 99(3):149-155. PubMed ID: 35584898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxis.
    Zeggagh J; Bauer R; Delaugerre C; Carette D; Fressard L; Charreau I; Chidiac C; Pialoux G; Tremblay C; Cua E; Robineau O; Raffi F; Capitant C; Spire B; Meyer L; Molina JM;
    AIDS; 2022 Jul; 36(8):1129-1134. PubMed ID: 35142708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of sexually transmitted infections and association with behavioural factors: Time-to-event analysis of a large pre-exposure prophylaxis (PrEP) cohort.
    Hovaguimian F; Kouyos RD; Kusejko K; Schmidt AJ; Tarr PE; Bernasconi E; Braun DL; Calmy A; Notter J; Stoeckle M; Surial B; Christinet V; Darling KEA; Depmeier C; Läuchli S; Reinacher M; Rasi M; Nicca D; Bruggmann P; Haerry D; Bize R; Low N; Vock F; El Amari EB; Böni J; Bosshard PP; Fehr JS; Hampel B;
    HIV Med; 2024 Jan; 25(1):117-128. PubMed ID: 37771207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
    Traeger MW; Cornelisse VJ; Asselin J; Price B; Roth NJ; Willcox J; Tee BK; Fairley CK; Chang CC; Armishaw J; Vujovic O; Penn M; Cundill P; Forgan-Smith G; Gall J; Pickett C; Lal L; Mak A; Spelman TD; Nguyen L; Murphy DA; Ryan KE; El-Hayek C; West M; Ruth S; Batrouney C; Lockwood JT; Hoy JF; Hellard ME; Stoové MA; Wright EJ;
    JAMA; 2019 Apr; 321(14):1380-1390. PubMed ID: 30964528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incident Cases of Sexually Transmitted Infections among Users of Pre-Exposure Prophylaxis for HIV Prevention in Honolulu, Hawai'i.
    Kiefer EM; Ross KS; Santos AC; Barney MR; McCormick TJ; Chow DC; Shikuma CM
    Hawaii J Health Soc Welf; 2021 Jul; 80(7):148-154. PubMed ID: 34278321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Sexual Behavior and Sexually Transmitted Infections After Initiating Human Immunodeficiency Virus Pre-Exposure Prophylaxis in Men Who Have Sex with Men from Amsterdam, the Netherlands: A Longitudinal Exposure-Matched Study.
    Coyer L; Prins M; Davidovich U; van Bilsen WPH; Schim van der Loeff MF; Hoornenborg E; Matser A; Boyd A
    AIDS Patient Care STDS; 2022 Jun; 36(6):208-218. PubMed ID: 35687814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV pre-exposure prophylaxis and diagnoses of sexually transmitted infections - observational data from German checkpoints, 01/2019-08/2021.
    Marcus U; Schink SB; Weber C
    BMC Public Health; 2023 Apr; 23(1):661. PubMed ID: 37029369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sexually Transmitted Infection Screening Among Gay, Bisexual, and Other Men Who Have Sex With Men Prescribed Pre-exposure Prophylaxis in Baltimore City, Maryland.
    Schumacher C; Wu L; Chandran A; Fields E; Price A; Greenbaum A; Jennings JM;
    Clin Infect Dis; 2020 Dec; 71(10):2637-2644. PubMed ID: 31761944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemsex and incidence of sexually transmitted infections among Canadian pre-exposure prophylaxis (PrEP) users in the l'Actuel PrEP Cohort (2013-2020).
    Flores Anato JL; Panagiotoglou D; Greenwald ZR; Blanchette M; Trottier C; Vaziri M; Charest L; Szabo J; Thomas R; Maheu-Giroux M
    Sex Transm Infect; 2022 Dec; 98(8):549-556. PubMed ID: 35039437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-exposure prophylaxis and bacterial sexually transmitted infections (STIs) among gay and bisexual men.
    Hart TA; Noor SW; Berlin GW; Skakoon-Sparling S; Tavangar F; Tan D; Lambert G; Grace D; Lachowsky NJ; Jollimore J; Sang J; Parlette A; Lal A; Apelian H; Moore D; Cox J;
    Sex Transm Infect; 2023 May; 99(3):167-172. PubMed ID: 35701145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany.
    Schmidt D; Kollan C; Bartmeyer B; Bremer V; Schikowski T; Friebe M; Schellberg S; Scholten S; Bickel M; Hanhoff N; Rüsenberg R; Schewe K;
    Infection; 2023 Jun; 51(3):665-678. PubMed ID: 36168098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Reported PrEP Use and Risk of Bacterial STIs Among Ontarian Men Who Are Gay or Bisexual or Have Sex With Men.
    Tran NK; Welles SL; Roy JA; Brennan DJ; Chernak E; Goldstein ND
    Ann Fam Med; 2024 Sep; 22(5):437-443. PubMed ID: 39191461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial sexually transmitted infections among men who have sex with men and transgender women using oral pre-exposure prophylaxis in Latin America (ImPrEP): a secondary analysis of a prospective, open-label, multicentre study.
    Torres Silva MS; Torres TS; Coutinho C; Ismério Moreira R; da Costa Leite I; Cunha M; da Costa Leite PHA; Cáceres CF; Vega-Ramírez H; Konda KA; Guanira J; Valdez Madruga J; Wagner Cardoso S; Benedetti M; Pimenta MC; Hoagland B; Grinsztejn B; Gonçalves Veloso V;
    Lancet HIV; 2024 Oct; 11(10):e670-e679. PubMed ID: 39243787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxis.
    Tang EC; Vittinghoff E; Philip SS; Doblecki-Lewis S; Bacon O; Chege W; Coleman ME; Elion R; Buchbinder S; Kolber MA; Liu AY; Cohen SE
    AIDS; 2020 Jul; 34(8):1181-1186. PubMed ID: 32205724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention.
    Oware K; Adiema L; Rono B; Violette LR; McClelland RS; Donnell D; Scoville CW; Odoyo J; Baeten JM; Bukusi E; Stewart J
    BMC Womens Health; 2023 Jun; 23(1):296. PubMed ID: 37270546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexually transmitted infections incidence in young Thai men who have sex with men and transgender women using HIV pre-exposure prophylaxis.
    Songtaweesin WN; Pornpaisalsakul K; Kawichai S; Wacharachaisurapol N; Wongharn P; Yodkitudomying C; Panichnantakul P; Theerawit T; Pankam T; Puthanakit T
    Int J STD AIDS; 2022 Apr; 33(5):447-455. PubMed ID: 35282719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying heterogeneity in sexual behaviour and distribution of STIs before and after pre-exposure prophylaxis among men who have sex with men.
    van Wees DA; Diexer S; Rozhnova G; Matser A; den Daas C; Heijne J; Kretzschmar M
    Sex Transm Infect; 2022 Sep; 98(6):395-400. PubMed ID: 34716228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.